Articles by Disease (Lipoatrophic Diabetes)

Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3339-3351
Author(s): Feeney Eoin R. and Mallon Patrick W.G.

Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3352-3360
Author(s): Martine Caron-Debarle, Franck Boccara, Claire Lagathu, Benedicte Antoine, Pascale Cervera, Jean-Philippe Bastard, Corinne Vigouroux and Jacqueline Capeau

Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3361-3371
Author(s): Metodi V. Stankov and Georg M.N. Behrens

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment

Journal: Current Pharmaceutical Design
Volume: 16
Page: 3372-3378
Author(s): Marta Giralt, Julieta Diaz-Delfin, Jose M. Gallego-Escuredo, Joan Villarroya, Pere Domingo and Francesc Villarroya

Winning a Won Game: Caffeine Panacea for Obesity Syndemic

Journal: Current Neuropharmacology
Volume: 8
Page: 149-160
Author(s): M. Myslobodsky and A. Eldan

SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10
Page: 16-24
Author(s): Shinji Kume, Takashi Uzu, Atsunori Kashiwagi and Daisuke Koya

Articles by Disease (Lipoatrophic Diabetes)

Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation

Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations

Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment

Winning a Won Game: Caffeine Panacea for Obesity Syndemic

SIRT1, a Calorie Restriction Mimetic, in a New Therapeutic Approach for Type 2 Diabetes Mellitus and Diabetic Vascular Complications

Potential Role of IL-18 in the Immunopathogenesis of AIDS, HIVAssociated Lipodystrophy and Related Clinical Conditions

Targeting MCP-1 to Reduce Vascular Complications of Obesity

Leptin in Non-Autoimmune Inflammation

Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment